DE1770092A1 - Oxadiazolderivate - Google Patents

Oxadiazolderivate

Info

Publication number
DE1770092A1
DE1770092A1 DE19681770092 DE1770092A DE1770092A1 DE 1770092 A1 DE1770092 A1 DE 1770092A1 DE 19681770092 DE19681770092 DE 19681770092 DE 1770092 A DE1770092 A DE 1770092A DE 1770092 A1 DE1770092 A1 DE 1770092A1
Authority
DE
Germany
Prior art keywords
oxadiazole
compound
formula
formaldehyde
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681770092
Other languages
English (en)
Inventor
Claisse John Anthony
Gregory Gordon Ian
Warburton William Kingston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of DE1770092A1 publication Critical patent/DE1770092A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/20Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/24Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/071,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Claims (23)

P.A. 186043 * 29-3.68 Patentansprüche
1. Verbindungen der Formel
G-B-R7 A
in der A eine der "beiden folgenden Gruppen ist
HN HC . j
\ ' H2C X
und B eine der beiden nachfolgenden Gruppen ist
R^l Ro
(in welcher R. und Rp Wasserstoff, Halogen oder niedrig-Alkyl sind) und R5, entweder Aryl, substituiertes Aryl, Oxadiazolyl, öxadiazolinyl oder Thienyl ist.
2. Verbindungen nach Anspruch 1, in denen die Gruppe R-, entweder Phenyl, Halophenyl, Azidophenyl, Cyanophenyl, Nitrophenyl, Aminophenyl, niedrig-Alkylphenyl, Hydroxyphenyl, niedrig-Al te j xyphenyl, Trif lourmethylphenyl, niedrig-Alkyl fchxophenyl,
109882/1788
SiNAL INSPECTED
niedrig-Alkylsulfinylphenyl, niedrig-Alkylsulfonylphenyl, Formamidophenyl oder Thiocyanotophenyl ist.
3. 3-Styryl-1,2,4-oxadiazol.
4-· 3-(p-Chlorstyryl)-i,2,4-oxadiazol.
5. 4,5-Dihydro-3-(p-chlorstyryl)-1,2,4-oxadiazol.
6. 1,2-bis(1,2-Oxadia2,ol-3-yl)äthylen.
7· 3-p-(Cyanostyryl)-1,2,4-oxadiazol.
8. 3-(p-Bromsfcyryl)-1,2,4-oxadiazol.
9· 4,5-Dihydro-3-(p-bromstyryl)-1,2,4-oxadiazol.
10. 3-(p-Fluorstyryl)-1,2,4-oxadiazol.
11. 4,5-Dihydro-3-(p-fluorstyryl)-1,2,4-oxadiazol.
12. 3-(p-Azidostyryl)-1,2,4-oxadiazol.
13· 3-(p-Methylsulfinylstyryl)-1,2,4-oxadiazol.
14. 3-(p-Trifluormethylstyryl)-1,2,4-oxadiazol.
15. 3-Phenyläthinyl-1,2,4-oxadiazol.
16. 3-(p-Chlorphenyläthinyl)-1,2,4-oxadiazol.
17. Verwendung von Verbindungen nach Anspruch 1, zusammen mit einem Träger- oder Verdünnungsmittel, als antiparasitische Zusammensetzungen.
18. Verfahren zur Herstellung von Verbindungen der Formel I:
XN C— CR
Her ν
109882/17
in der R,- und Rp, die gleich oder verschieden sein können, jeder ein Wasserstoffatom, ein Halogenatom oder eine Alkylgruppe mit 1 bis 5 Kohlenstoffatomen bedeuten oder R^ und R2 zusammen mit den Kohlenstoffatomen, an die sie gebunden sind, eine Kohlenstoff-Kohlenstoff-Bindung bilden; R7 einen Aryl-, Oxadiazolyl-, Oxadiazolinyl- oder Thienylrest bedeutet, wobei jede der Gruppen substituiert sein kann; und X und X beide Wasserstoffatome bedeuten oder zusammen eine Stickstoff-Kohlenstoff-Bindung bilden, dadurch gekennzeichnet, daß eine Verbindung der Formel II
Ηρα.
C-
mit einem Formylierungsmittel oder Formaldehyd oder polymerem Formaldehyd umgesetzt wird und die Gruppe R, im Produkt gewünschtenfalls in bekannter Weise in eine andere Gruppe R? umgewandelt wird.
19. Verfahren nach Anspruch 18, dadurch gekennzeichnet, daß das Formylierungsmittel ein Alkylorthoformiat, Ameisen— säure, Formamid, ein gemischtes Anhydrid mit Ameisensäure, ein Formylhalogenid oder ein Komplex aus Formamid und Fhosphoroxychlorid ist.
20. Verfahren nach einem der Ansprüche 18 oder 19S dadurch gekcnnzeichnet,laß die Formylierung in Gegenwart eines Säure-
109882/1788
oder Lewis-Säurekatalysators durchgeführt wird·
21. Verfahren nach einem der Ansprüche 18 bis 20, dadurch gekennzeichnet, daß die Formulierung in Gegenwart eines Lösungsmittels durchgeführt wird.
22. Verfahren nach einem der Ansprüche 18 bis 21, dadurch gekennzeichnet, daß die Verbindung der Formel I mit Formaldehyd oder einem polymeren Formaldehyd umgesetzt wird und die entstandene Verbindung oxydiert wird.
23. Verfahren nach einem der Ansprüche 18 bis 22, dadurch gekennzeichnet, daß wenn das Reaktionsprodukt eine trans_-Verbindung ist, diese Verbindung durch Photoisomerisierung in die entsprechende eis-Verbindung umgewandelt wird.
θΓ,-iccha-
Q nicht
sind.
109882/1788
DE19681770092 1967-03-31 1968-03-29 Oxadiazolderivate Pending DE1770092A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1496167 1967-03-31
US47306474A 1974-05-24 1974-05-24
US05/556,324 US4012377A (en) 1967-03-31 1975-03-07 Oxadiazole and oxadiazoline derivatives

Publications (1)

Publication Number Publication Date
DE1770092A1 true DE1770092A1 (de) 1972-01-05

Family

ID=27257195

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681770092 Pending DE1770092A1 (de) 1967-03-31 1968-03-29 Oxadiazolderivate

Country Status (7)

Country Link
US (1) US4012377A (de)
CH (1) CH502364A (de)
DE (1) DE1770092A1 (de)
DK (1) DK124826B (de)
FR (2) FR1579544A (de)
GB (1) GB1228142A (de)
NL (1) NL6804496A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4212970A (en) * 1977-11-28 1980-07-15 Fuji Photo Film Co., Ltd. 2-Halomethyl-5-vinyl-1,3,4-oxadiazole compounds
DE3622296A1 (de) * 1986-07-03 1988-01-07 Basf Ag Verfahren zur herstellung von (beta)-halogenvinyl- und (beta),(beta)-dihalogenethylarylketonen
DE4041474A1 (de) * 1990-12-22 1992-06-25 Bayer Ag Verwendung von substituierten 1,2,4-oxadiazolderivaten zur bekaempfung von endoparasiten, neue substituierte 1,2,4-oxadiazolderivate und verfahren zu ihrer herstellung
DE4124151A1 (de) * 1991-07-20 1993-01-21 Bayer Ag Insektizide und akarizide pflanzenschutzmittel enthaltend substituierte 1,2,4-oxadiazolderivate
DE4232418A1 (de) * 1992-09-28 1994-03-31 Bayer Ag Verwendung von substituierten 1,2,4-Oxadiazolderivaten zur Bekämpfung von Endoparasiten, neue substituierte 1,2,4-Oxadiazolderivate und Verfahren zu ihrer Herstellung
FR2735473A1 (fr) * 1995-06-13 1996-12-20 Hoechst Schering Agrevo Sa Nouveaux derives de l'acide beta-methoxy acrylique, leur procede de preparation et leur application comme pesticides
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
ATE306489T1 (de) 1999-03-08 2005-10-15 Medicure Inc Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
CA2376029A1 (en) 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
JP2003507418A (ja) 1999-08-24 2003-02-25 メディキュア インターナショナル インコーポレイテッド 心血管疾患とその関連疾患の治療
WO2001064692A1 (en) 2000-02-29 2001-09-07 Medicure International Inc. Cardioprotective phosphonates and malonates
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
AU2001272263B2 (en) 2000-07-07 2005-12-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US20060019929A1 (en) * 2004-07-07 2006-01-26 Albert Friesen Combination therapies employing platelet aggregation drugs
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
CA2585165A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
WO2007059631A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies
WO2008097538A1 (en) * 2007-02-08 2008-08-14 Merck & Co., Inc. Therapeutic agents
RU2009144998A (ru) * 2007-05-07 2011-06-20 Шеринг Корпорейшн (US) Модуляторы гамма-секретазы
WO2010054064A1 (en) * 2008-11-06 2010-05-14 Schering Corporation Gamma secretase modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL291628A (de) * 1962-04-17
NL302339A (de) * 1963-03-22
US3574222A (en) * 1965-12-29 1971-04-06 Mallinckrodt Chemical Works Preparation of 5-amino-1,2,4-oxadiazoles
DE1670338A1 (de) * 1966-03-14 1972-08-10 Heyden Chem Fab Verfahren zur Herstellung von antimikrobiell wirksamen Nitrofuranderivaten
US3471621A (en) * 1966-05-02 1969-10-07 Gulf Research Development Co Method of combating nematodes with 3-cyclopropyl - 5 - dichloromethyl-1,2,4-oxadiazole
US3356684A (en) * 1966-07-28 1967-12-05 Lilly Co Eli Novel compositions for the treatment of helminthiasis
US3637707A (en) * 1970-11-24 1972-01-25 Pfizer 2-(substituted) 2-thiazolines for the control of rice blast

Also Published As

Publication number Publication date
US4012377A (en) 1977-03-15
DK124826B (da) 1972-11-27
NL6804496A (de) 1968-10-01
GB1228142A (de) 1971-04-15
CH502364A (de) 1971-01-31
FR1579544A (de) 1969-08-29
FR8333M (de) 1970-12-14

Similar Documents

Publication Publication Date Title
DE1770092A1 (de) Oxadiazolderivate
DE1695271A1 (de) Schaedlingsbekaempfungsmittel
DE2047846C3 (de) 4-Piperidonenoläther, Verfahren zu deren Herstellung und deren Verwendung zum Stabilisieren von synthetischen Polymeren
DE2228379A1 (de) Stabilisierte klebstoffe
DE1232968B (de) Verfahren zur Herstellung von N, N', N"- Tris-(dibrompropionyl)-hexahydrotriazin
DE2431796A1 (de) Verfahren zur herstellung von n,n, n',n'-tetraarylchinondiimonium-salzen
DE810458C (de) Verfahren zum Sensibilisieren photographischer Emulsionen
DE1804528A1 (de) Verfahren zur Herstellung von Polyolefinoxiden mit erhoehtem Molgewicht
DE1645457B2 (de) Verfahren zur Herstellung von stabilisierten Polyamiden und deren Verwendung für Formgegenstände
DE1179365B (de) Verfahren zum Stabilisieren von Acrylnitril-polymerisat-Loesungen
DE1645034A1 (de) Verfahren zur Herstellung fluorierter polymerer Materialien
DE721196C (de) Verfahren zur Umwandlung loeslicher, schmelzbarer Aminoplaste in den unloeslichen, unschmelzbaren Zustand
DE2440597B2 (de) Verfahren zur Herstellung von vernetzbaren Polyäthylen-Massen
DE1005267B (de) Beschleunigungsmittel in haertbaren Giessharzgemischen aus ungesaettigten Polyestern und monomeren, hieran anpolymerisierbaren Verbindungen
DE1143025B (de) Verfahren zum Stabilisieren von Polyoxymethylenen
DE2157844C3 (de) Haarfärbemittel
DE1932306A1 (de) Verfahren zur Herstellung von N-Glykoluril-Derivaten
AT272641B (de) Verfahren zur Herstellung von Vinylchloridpolymerisaten und/oder -copolymerisaten
DE718767C (de) Verfahren zum Nachweis von Ammoniak mittels Kupfersalzloesungen
AT230090B (de) Verfahren zur Polymerisation von Mono-α-olefinen mit drei oder mehr Kohlenstoffatomen
DE1801150A1 (de) Formmassen aus Polyolefinen
DE1539841A1 (de) Benzoxazol-Derivate als Scintillator-Substanzen
AT235583B (de) Verfahren zur Herstellung von linearen synthetischen Polyamiden
DE1187371B (de) Verfahren zum Aushaerten von Polyester-Formmassen
DE1105416B (de) Verfahren zur Herstellung von neuen, kristallisierbaren Titan und Aluminium enthaltenden metallorganischen Komplexverbindungen